Abnormal liver tests in people aged 75 and above: Prevalence and association with mortality

Alimentary Pharmacology and Therapeutics

Volumn 34, Issue 3, 2011, Pages 324-334

  Fleming, K M ^a   West, J ^a,b   Aithal, G P ^b   Fletcher, A E ^c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ABNORMAL LIVER TEST; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; LIVER DISEASE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COHORT STUDIES; FEMALE; GREAT BRITAIN; HUMANS; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; PREDICTIVE VALUE OF TESTS; PREVALENCE;

EID: 79959945852     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04718.x     Document Type: Article

References (20)

1. NICE Implementation Uptake Report: Statins. Available at:.
2. British National Formulary. British Medical Association. London: Royal Pharmaceutical Society of Great Britain, 2008.
3. Bader T,. The myth of statin-induced hepatotoxicity. Am J Gastroenterol 2010; 105: 978-80.
4. Athyros VG, Tziomalos K, Gossios TD, et al. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet 2010; 376: 1916-22.
5. Schindhelm RK, Dekker JM, Nijpels G, et al. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis 2007; 191: 391-6. (Pubitemid 46400701)
6. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I,. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 2004; 328: 983.
7. Lee TH, Kim WR, Benson JT, Therneau TM, Melton LJ 3rd,. Serum aminotransferase activity and mortality risk in a United States community. Hepatology 2008; 47: 880-7. (Pubitemid 351449679)
8. McLernon DJ, Donnan PT, Ryder S, et al. Health outcomes following liver function testing in primary care: a retrospective cohort study. Fam Pract 2009; 26: 251-9.
9. Fletcher AE, Jones DA, Bulpitt CJ, Tulloch AJ,. The MRC trial of assessment and management of older people in the community: objectives, design and interventions [ISRCTN23494848]. BMC Health Serv Res 2002; 2: 21.
10. Fletcher AE, Price GM, Ng ES, et al. Population-based multidimensional assessment of older people in UK general practice: a cluster-randomised factorial trial. Lancet 2004; 364: 1667-77. (Pubitemid 39458142)
11. Jarman B,. Underprivileged areas: validation and distribution of scores. Br Med J (Clin Res Ed) 1984; 289: 1587-92.
12. Osborn DP, Fletcher AE, Smeeth L, et al. Factors associated with depression in a representative sample of 14 217 people aged 75 and over in the United Kingdom: results from the MRC trial of assessment and management of older people in the community. Int J Geriatr Psychiatry 2003; 18: 623-30. (Pubitemid 36903390)
13. Rose GA,. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962; 27: 645-58.
14. Folstein MF, Folstein SE, McHugh PR,. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
15. World Health Organization. Physical Status: The use and Interpretation of Anthropometry. Report of a WHO Expert Committee (Technical Report Series, No 854). Geneva: WHO, 1995.
16. Clark JM, Brancati FL, Diehl AM,. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003; 98: 960-7. (Pubitemid 36733754)
17. Ioannou GN, Boyko EJ, Lee SP,. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol 2006; 101: 76-82. (Pubitemid 43381712)
18. Arndt V, Brenner H, Rothenbacher D, Zsxhenderlein B, Fraisse E, Fliedner TM,. Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality. Int Arch Occup Environ Health 1998; 71: 405-12. (Pubitemid 28438418)
19. Elinav E, Ackerman Z, Maaravi Y, Ben-Dov IZ, Ein-Mor E, Stessman J,. Low alanine aminotransferase activity in older people is associated with greater long-term mortality. J Am Geriatr Soc 2006; 54: 1719-24. (Pubitemid 44665211)
20. Department of Health Quality Strategy Team Report. Liver Disease: A Scoping Study Into the Nature and Burden of the Disease. London: Department of Health, 2006.